HOME >> BIOLOGY >> NEWS
Viral marker of human migration suspect

A benign virus previously used as a marker in tracing human migration may be unreliable, according to researchers at Penn State. Results of this study also suggest that some viruses might be undergoing much higher rates of evolution than previously thought.

"The most genetically divergent human populations are in Africa," said Laura Shackelton, a postdoctoral researcher at Penn State's Center for Infectious Disease Dynamics. "But, in the case of this virus, strains from European communities appear to be the most divergent."

The human polyomavirus, or JCV, is a small double-stranded DNA virus that is thought to be primarily transmitted from parents to their children. Infection is usually asymptomatic unless a person has a weak immune system, in which case the virus can cause neurological disease.

There are more than 14 subtypes of the virus, each primarily associated with different human populations such as African, Japanese, South Asian, and European. Population geneticists have assumed that the virus has been with humans since their emergence from Africa.

"Because of this presumed codivergence with human populations, JCV has been widely used as a genetic marker for human evolution and migration," explained Shackelton, whose findings appear this month (October) in the Journal of Virology.

The researchers note that while previous studies of genetic variation have observed some differences between the distribution of JCV and human populations, the extent of the differences in their evolutionary histories has never been fully tested.

Shackelton and her colleagues analyzed 333 genetic sequences of the virus and reconstructed their evolutionary history. They then compared this history to the reconstructed history of human populations, based on mitochondrial DNA.

"If the virus had been with humans since we were a single population, and we have almost strictly transmitted it to our children, you may expect that as populatio
'"/>

Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
24-Oct-2006


Page: 1 2

Related biology news :

1. Viral enzyme recruited in fight against ear infection
2. Viral protein is an effective preventative against infection
3. Viral oncoprotein inactivation of p53
4. Viral genetic differences are possible key to HIV dementia
5. Viral hitchhiker inhibits Wolbachia bacterias ability to proliferate
6. Viral protein helps infected T cells stick to uninfected cells
7. Viral fitness explains different resistance patterns to aids drugs
8. Viral protein influences key cell-signaling pathway
9. Research aims to identify markers for menopausal women at risk for deadly blood clot
10. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
11. Cell receptor may lead to new biomarker for pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... ... June 11, 2020 , ... Bode ... expansion of its forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) ... genealogy and DNA analysis methods. The team has added experienced genealogists, each having ...
(Date:6/11/2020)... ... , ... Superior Controls, Inc. , an E Technologies Company and leading ... sciences industry, is pleased to announce the recent hiring of Ray Boudreau, who will ... Hampshire office. In his new role, Boudreau will use his extensive experience with ...
(Date:6/5/2020)... ... ... “Although we are disappointed to have to make this decision our primary ... We remain committed to creating a global platform to showcase the science, and ... of WMIS. , The abstract deadline for the virtual meeting is ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic ... drug treatment. In an effort to better understand the cellular responses to COVID-19, ... imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules ...
(Date:6/23/2020)... BOSTON (PRWEB) , ... June 23, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced the availability of ... Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry ...
(Date:6/23/2020)... ... 2020 , ... Dracen Pharmaceuticals Inc., announced today that two ... the American Association for Cancer Research Virtual meeting. One poster describes the immuno-metabolism ... agent activity in KEAP1 mutant tumor models of NSCLC. , “As ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... delivered through the use of proprietary clean viral vectors, recently announced a key ... States. Greffex’s platform is the world’s most successful gene therapy delivery vehicle ...
Breaking Biology Technology:
Cached News: